Jacc Cardiovasc Imaging

• 

  Publication Venue For

  • Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop. 2020
  • Impact of Agreement and Discrepancies in Interpretations of Stress Echocardiography: Insights From the PROMISE Trial..  13:2048-2050. 2020
  • Sex Differences in Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Lessons From ADVANCE. 2020
  • Cardiac Imaging in the Post-ISCHEMIA Trial Era: A Multisociety Viewpoint..  13:1815-1833. 2020
  • Prognostic Value of Coronary CTA in Stable Chest Pain: CAD-RADS, CAC, and Cardiovascular Events in PROMISE..  13:1534-1545. 2020
  • Left Ventricular Intramyocardial Fat Detected on Cardiac Computed Tomography in Patients With Stable Chest Pain..  13:1282-1284. 2020
  • Feature-Tracking Global Longitudinal Strain Predicts Mortality in Patients With Preserved Ejection Fraction: A Multicenter Study..  13:940-947. 2020
  • Machine Learning in Medical Imaging: All Journeys Begin With a Single Step..  13:696-698. 2020
  • 1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry..  13:97-105. 2020
  • Core Competencies in Echocardiography for Imaging Structural Heart Disease Interventions: An Expert Consensus Statement..  12:2560-2570. 2019
  • Left Ventricular Noncompaction: Meglio solo che mal accompagnati: Italian proverb: "Better Alone Than in Bad Company"..  12:2152-2154. 2019
  • Prognostic Implications of Mitral Annular Plane Systolic Excursion in Patients with Hypertension and a Clinical Indication for Cardiac Magnetic Resonance Imaging: A Multicenter Study..  12:1769-1779. 2019
  • Controversies in Diagnostic Imaging of Patients With Suspected Stable and Acute Chest Pain Syndromes..  12:1254-1278. 2019
  • High-Sensitivity Troponin I and Coronary Computed Tomography in Symptomatic Outpatients With Suspected CAD: Insights From the PROMISE Trial..  12:1047-1055. 2019
  • Identification of High-Risk Plaques Destined to Cause Acute Coronary Syndrome Using Coronary Computed Tomographic Angiography and Computational Fluid Dynamics..  12:1032-1043. 2019
  • Implications of Left Ventricular Geometry in Low-Flow Aortic Stenosis: A PARTNER 2 Trial Subanalysis..  12:367-368. 2019
  • Comprehensive Echocardiographic Assessment of Normal Transcatheter Valve Function..  12:25-34. 2019
  • Dark-Blood Delayed Enhancement Cardiac Magnetic Resonance of Myocardial Infarction..  11:1758-1769. 2018
  • A Tale of 2 Tests..  11:1298-1300. 2018
  • Comparison of International Guidelines for Assessment of Suspected Stable Angina: Insights From the PROMISE and SCOT-HEART..  11:1301-1310. 2018
  • Definition of Left Ventricular Segments for Cardiac Magnetic Resonance Imaging..  11:926-928. 2018
  • A Randomized Trial of Pocket-Echocardiography Integrated Mobile Health Device Assessments in Modern Structural Heart Disease Clinics..  11:546-557. 2018
  • The External Validity of Prediction Models for the Diagnosis of Obstructive Coronary Artery Disease in Patients With Stable Chest Pain: Insights From the PROMISE Trial..  11:437-446. 2018
  • Cardiovascular Imaging With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients With Fibroinflammatory Disorders..  11:365-368. 2018
  • The Authors Reply..  11:285-286. 2018
  • Cardiac-Specific Conversion Factors to Estimate Radiation Effective Dose From Dose-Length Product in Computed Tomography..  11:64-74. 2018
  • The Prevalence, Correlates, and Impact on Cardiac Mortality of Right Ventricular Dysfunction in Nonischemic Cardiomyopathy..  10:1225-1236. 2017
  • Radiation Safety in Children With Congenital and Acquired Heart Disease: A Scientific Position Statement on Multimodality Dose Optimization From the Image Gently Alliance..  10:797-818. 2017
  • Comparative Effectiveness Trials of Imaging-Guided Strategies in Stable Ischemic Heart Disease..  10:321-334. 2017
  • Outcomes-Based CV Imaging Research Endpoints and Trial Design: From Pixels to Patient Satisfaction..  10:253-263. 2017
  • Randomized Trials in Cardiovascular Imaging: Where to Next?.  10:381-383. 2017
  • The Author Replies..  10:98-99. 2017
  • Long-Term Valve Performance of TAVR and SAVR: A Report From the PARTNER I Trial. 2016
  • CMR First-Pass Perfusion for Suspected Inducible Myocardial Ischemia..  9:1338-1348. 2016
  • The Future of Cardiac Imaging: Report of a Think Tank Convened by the American College of Cardiology..  9:1211-1223. 2016
  • Coronary Artery Disease - Reporting and Data System (CAD-RADS): An Expert Consensus Document of SCCT, ACR and NASCI: Endorsed by the ACC..  9:1099-1113. 2016
  • Safety and Efficacy of Self-Expanding TAVR in Patients With Aortoventricular Angulation..  9:973-981. 2016
  • Expanding CT Application to Myocardial Tissue Characterization..  9:846-848. 2016
  • Echocardiographic Algorithm for Post-Myocardial Infarction LV Thrombus: A Gatekeeper for Thrombus Evaluation by Delayed Enhancement CMR..  9:505-515. 2016
  • Gender Differences in Radiation Dose From Nuclear Cardiology Studies Across the World: Findings From the INCAPS Registry..  9:376-384. 2016
  • Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial..  9:337-346. 2016
  • Echocardiography in Clinical Trials for TAVR: Getting to the Core of the Matter..  8:1376-1378. 2015
  • Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization..  8:1121-1129. 2015
  • Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population..  8:1034-1041. 2015
  • Performance of CMR Methods for Differentiating Acute From Chronic MI..  8:669-679. 2015
  • Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement..  8:288-318. 2015
  • Cardiovascular imaging utilization: boom or bust?.  7:701-702. 2014
  • Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging..  7:593-604. 2014
  • Impaired resting myocardial annular velocities are independently associated with mental stress-induced ischemia in coronary heart disease..  7:351-361. 2014
  • Prognostic value of PET myocardial perfusion imaging in obese patients..  7:278-287. 2014
  • CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis..  7:143-156. 2014
  • MR spectroscopy of cholesteryl ester in human atherosclerosis..  6:1285-1286. 2013
  • Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction..  6:851-860. 2013
  • Healthcare reform for imagers: finding a way forward now..  6:385-391. 2013
  • Prosthetic valve thrombosis: when and how should we lyse?.  6:217-219. 2013
  • Patterns and predictors of stress testing modality after percutaneous coronary stenting: data from the NCDR(®)..  5:969-980. 2012
  • Extracellular space measurements with CMR imaging..  5:908-910. 2012
  • Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction..  5:715-724. 2012
  • A practical guide to multimodality imaging of transcatheter aortic valve replacement..  5:441-455. 2012
  • T2-weighted imaging to assess post-infarct myocardium at risk..  4:1014-1021. 2011
  • LV thrombus detection by routine echocardiography: insights into performance characteristics using delayed enhancement CMR..  4:702-712. 2011
  • Prognostic value of CT angiography in patients with inconclusive functional stress tests..  4:740-751. 2011
  • Improved near-term coronary artery disease risk classification with gated stress myocardial perfusion SPECT..  3:1139-1148. 2010
  • Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease..  3:734-745. 2010
  • Cardiovascular imaging research at the crossroads..  3:316-324. 2010
  • Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis..  3:144-151. 2010
  • Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial..  3:52-60. 2010
  • Electroanatomic relationships in patients with primum atrioventricular septal defect..  2:1357-1365. 2009
  • Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus..  2:969-979. 2009
  • In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study..  2:858-868. 2009
  • Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute..  2:897-907. 2009
  • Achieving Quality in Cardiovascular Imaging II: proceedings from the Second American College of Cardiology -- Duke University Medical Center Think Tank on Quality in Cardiovascular Imaging..  2:231-240. 2009
  • The Imaging Council of the American College of Cardiology..  1:812-814. 2008
  • Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure..  1:595-601. 2008
  • Extracardiac findings: what is a cardiologist to do?.  1:682-687. 2008
  • Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study..  1:582-591. 2008
  • The multimodality imager: reality or fantasy?.  1:518-521. 2008
  • Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women..  1:436-445. 2008
  • A new era for cardiovascular imaging? Implications of the revoked national coverage decision for CT angiography on future imaging reimbursement..  1:398-403. 2008
  • Imaging for coronary risk assessment: ready for prime time?.  1:263-265. 2008
  • Impaired coronary vasodilation by magnetic resonance angiography is associated with advanced coronary artery calcification..  1:167-173. 2008
  • Contrast echocardiography: past, present, and...future?.  1:107-110. 2008
  • The Prognostic Value of Diastolic and Systolic Mechanical Left Ventricular Dyssynchrony Among Patients With Coronary Heart Disease. 2019
  • The Impact of a Rigorous Quality Program on 3D Echocardiography Data Quality in an International Multisite Randomized Trial. 2018